Efficacy of teduglutide in a patient with Crohn's disease and short bowel syndrome on enteral nutrition: let's start to think out of the box.
作者信息
Barberio Brigida, Sturniolo Giacomo Carlo, D'Incà Renata, Farinati Fabio, Bigotto Maria Assunta, Ghisa Matteo, Lorenzon Greta, Savarino Edoardo
机构信息
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Department of Pharmaceutical Sciences, University of Padua, Padua, Italy.
出版信息
Gastroenterol Rep (Oxf). 2019 Jul 13;7(6):459-460. doi: 10.1093/gastro/goz030. eCollection 2019 Dec.
Abstract
摘要
相似文献
1
Efficacy of teduglutide in a patient with Crohn's disease and short bowel syndrome on enteral nutrition: let's start to think out of the box.替度鲁肽对一名克罗恩病合并短肠综合征患者肠内营养的疗效：让我们开始跳出框框思考。
Gastroenterol Rep (Oxf). 2019 Jul 13;7(6):459-460. doi: 10.1093/gastro/goz030. eCollection 2019 Dec.
2
Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.替度鲁肽（Gattex）用于克罗恩病患者及因短肠综合征相关肠衰竭而需要肠外支持的安全性和有效性
J Clin Gastroenterol. 2017 Jul;51(6):508-511. doi: 10.1097/MCG.0000000000000604.
3
Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.单中心应用特度鲁肽治疗成人短肠综合征的经验。
JPEN J Parenter Enteral Nutr. 2018 Jan;42(1):225-230. doi: 10.1002/jpen.1011. Epub 2017 Dec 13.
4
Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.替度鲁肽治疗小儿短肠综合征的12周开放标签多中心临床试验结果
J Pediatr. 2017 Feb;181:102-111.e5. doi: 10.1016/j.jpeds.2016.10.027. Epub 2016 Nov 15.
5
Teduglutide-Stimulated Intestinal Adaptation Is Complemented and Synergistically Enhanced by Partial Enteral Nutrition in a Neonatal Piglet Model of Short Bowel Syndrome.特杜古肽刺激的肠道适应在短肠综合征新生仔猪模型中通过部分肠内营养得到补充和协同增强。
JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):853-865. doi: 10.1177/0148607115602891. Epub 2015 Aug 24.
6
Teduglutide for the treatment of short bowel syndrome - a safety evaluation.特度鲁肽治疗短肠综合征的安全性评价。
Expert Opin Drug Saf. 2018 Jul;17(7):733-739. doi: 10.1080/14740338.2018.1483332. Epub 2018 Jun 8.
7
Enteral nutrition improves health-related quality of life in Crohn's disease patients with long disease duration.肠内营养可改善病程较长的克罗恩病患者与健康相关的生活质量。
Hepatogastroenterology. 2009 Mar-Apr;56(90):321-7.
8
Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's disease.在健康受试者和短肠综合征及克罗恩病患者中，经重复皮下给药后，特杜格鲁肽的群体药代动力学。
J Clin Pharmacol. 2010 Jan;50(1):36-49. doi: 10.1177/0091270009342252. Epub 2009 Sep 22.
9
Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption.非肠道衰竭慢性吸收不良患者的特杜格鲁肽的标签外治疗。
Dig Dis Sci. 2019 Jun;64(6):1599-1603. doi: 10.1007/s10620-019-5473-5. Epub 2019 Feb 7.
10
Is there a role for bowel rest in nutrition management of Crohn's disease?肠道休息在克罗恩病营养管理中起作用吗？
Nutr Clin Pract. 2008 Jun-Jul;23(3):309-17. doi: 10.1177/0884533608318674.
引用本文的文献
1
Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease.在短肠综合征和克罗恩病患者中使用替度鲁肽与改善预后相关。
Crohns Colitis 360. 2024 Jan 24;6(1):otae007. doi: 10.1093/crocol/otae007. eCollection 2024 Jan.
2
Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure.胰高血糖素样肽-2 类似物在短肠综合征和肠衰竭的克罗恩病患者中的应用。
World J Gastroenterol. 2022 Nov 28;28(44):6258-6270. doi: 10.3748/wjg.v28.i44.6258.
本文引用的文献
1
Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.短肠综合征相关肠衰竭患者长期接受特度鲁肽治疗可减少肠外营养和水合支持，并提高安全性： STEPS-3 研究。
Nutr Clin Pract. 2018 Aug;33(4):520-527. doi: 10.1002/ncp.10092. Epub 2018 May 15.
2
Pharmacological strategies to enhance adaptation in intestinal failure.增强肠道衰竭适应性的药理学策略。
Curr Opin Organ Transplant. 2016 Apr;21(2):147-52. doi: 10.1097/MOT.0000000000000296.
3
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome.长效替度鲁肽治疗短肠综合征相关肠衰竭患者
Clin Transl Gastroenterol. 2016 Feb 4;7(2):e142. doi: 10.1038/ctg.2015.69.
4
Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.克罗恩病中的短肠综合征与肠衰竭
Inflamm Bowel Dis. 2016 May;22(5):1209-18. doi: 10.1097/MIB.0000000000000698.
5
Pathophysiology of short bowel syndrome: considerations of resected and residual anatomy.短肠综合征的病理生理学：对切除和残留解剖结构的考量
JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):14S-22S. doi: 10.1177/0148607113520005. Epub 2014 Feb 5.
6
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.随机安慰剂对照试验研究特杜格鲁肽减少短肠综合征患者肠外营养和/或静脉输液需求的作用。
Gut. 2011 Jul;60(7):902-14. doi: 10.1136/gut.2010.218271. Epub 2011 Feb 11.
7
Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.替度鲁肽（ALX-0600），一种对二肽基肽酶IV具有抗性的胰高血糖素样肽2类似物，可改善短肠综合征患者的肠道功能。
Gut. 2005 Sep;54(9):1224-31. doi: 10.1136/gut.2004.061440.
8
AGA technical review on short bowel syndrome and intestinal transplantation.美国胃肠病学会关于短肠综合征与肠道移植的技术综述
Gastroenterology. 2003 Apr;124(4):1111-34. doi: 10.1016/s0016-5085(03)70064-x.
9
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying.短肠综合征中的胃肠激素。肽YY可能是胃排空的“结肠刹车”。
Gut. 1996 Aug;39(2):267-72. doi: 10.1136/gut.39.2.267.
10
The colon influences ileal resection diarrhea.结肠会影响回肠切除术后腹泻。
Dig Dis Sci. 1980 Jan;25(1):33-41. doi: 10.1007/BF01312730.
Zotero 插件